Welcome to NevadaLifeSciences.com

This network addresses the growing informational and service needs of companies, patients, educators and others in their respective states while providing clients the opportunity to cost effectively advertise their job openings, events, facility availability and other services at the state level, regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting services.

Learn About Nevada's BioHistory

Through Nevada BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industries in the state of Nevada.

Local News...

Free News Release Posting & Archiving Service


• XOMA refinances royalty-based loan facility for $55 million  XOMA announced that it has entered into an amended loan facility under which it has borrowed $55 million from Goldman Sachs Specialty Lending Group, L.P. The loan is secured by the royalty revenues the Company receives from sales of RAPTIVA(r), LUCENTIS(r) and CIMZIA(r).
  XOMA Ltd.  May 12, 2008  
  
  
• XOMA reports first quarter 2008 financial results  XOMA announced its results for the quarter ended March 31, 2008. XOMA's total revenues were $12.1 million in the first quarter of 2008, compared to $12.3 million in the first quarter of 2007.
  XOMA Ltd.  May 12, 2008  
  
  
• Affymax and Takeda announce long-term hematide safety and effectiveness data  Takeda Global Research & Development Center and Affymax reported positive 12 month data from their ongoing Phase 2 trial(1) evaluating the safety and tolerability of Hematide(TM), an investigational drug in development for the treatment of anemia associated with chronic kidney disease.
  Affymax, Inc.  May 12, 2008  
  
  
• Neurobiological Technologies reports third quarter financial results  Neurobiological Technologies announced financial results for its fiscal third quarter and the nine months ended March 31, 2008. Revenues for the three months ended March 31, 2008 were $3.7 million compared to $4.9 million for the same three months last year.
  Neurobiological Technologies, Inc.  May 12, 2008  
  
  
• Isis reports financial results and highlights for first quarter of 2008  Isis Pharmaceuticals announced its financial results for the quarter ended March 31, 2008. Isis finished the quarter with a pro forma net operating loss of $5.1 million, excluding compensation expense from to stock options, compared to a pro forma NOL of $18.5 million in the first quarter of 2007.
  Isis Pharmaceuticals, Inc.  May 12, 2008  
  
  

More... | Submit News Release | National News

New Job Postings...

Free Job Posting Trial Offer

• Senior Toxicologist SNBL USA, Ltd. (WA)
• Technical Officer, Vaccine Stabilization PATH (WA)
• Associate Medical Director, Device Safety Allen Thomas Associates, Inc. (NJ)
• Quality Coordinator, Transfusion Services Laboratories Puget Sound Blood Center (WA)
• Preclinical Study Coordinator I, II, III SNBL USA, Ltd. (WA)

More... | Job Advertising... | About Job Postings...

Upcoming Events...

Free Event Posting Service

• 05/13/2008: Medical Device Breakfast: Reimbursement
• 05/13/2008: 2008 Healthcare Investor & Corporate Development Conference
• 05/13/2008: Recruiting 2008 Conference & Expo
• 05/14/2008: Introduction to Oncology and Chemotherapy
• 05/14/2008: BIOCOM May Breakfast Meeting

More... | Submit Event | Event Advertising...